Drug Discovery And Development Apac Companies - Top Drug Discovery And Development Consulting Services Companies In Apac

Pharma Tech Outlook: Pharma Tech Magazine

Mayne Contract Services: Supporting Drug Development-From Concept to Commercialization

Top 10 Drug Discovery And Development Consulting/Services Companies In APAC - 2020


With several breakthrough drugs reaching their patient cliffs, pharmaceutical companies and their service providers are in the constant pursuit to make drug development a more efficient process. And in the aftermath of advanced technologies, target-based drugs that focus on the patient’s genetic composition have emerged as the most potent weapon to pharmaceutical organizations. Not only do target-based drugs have minimal side effects on the adjoining genes or molecular mechanisms in the patient, but they are also less time-consuming and highly efficient. Besides, the use of advanced techniques likes High Throughput Screening (HTS), Quantitative Structure Activity Relationships (QSAR), and more are resulting in precision drug designs. Also, modern research disciplines such as proteomics, genomics, metabolomics, chemogenomics, and others are improving the drug discovery process at an alarming rate.

In the wake of such drastic transitions, we have compiled this issue of Pharma Tech Outlook in order to assist organizations in the task of finding accomplished solution providers and consulting/services companies to help them navigate the drug discovery and development realm. In this edition, we have listed the top 10 drug discovery and development solution providers in APAC – 2020 and top 10 drug discovery and development consulting/services companies in APAC – 2020 to highlight the enterprises that can escalate the chances of your growth. Equipped with innovative technological capabilities, these enlisted solution providers and consulting/services companies are transforming the drug discovery and development paradigm at the cloverleaf of various disruptive technologies. Besides, the magazine comprises insights from subject-matter experts, CIOs, and CXOs in the pharmaceutical sector on the latest industry trends, best practices, recent innovations, and highlights their expertise. We hope this issue of Pharma Tech Outlook helps you build the partnership you and your organization need to foster an environment driven by robust and efficient technology.

We present to you Pharma Tech Outlook’s, “Top 10 Drug Discovery and Development Solution Providers in APAC – 2020”

    Top Drug Discovery And Development Consulting/Services Companies In APAC

  • DM Intelligence is a pharmaceutical technology company focused on artificial intelligence researches, innovations and applications, and strives for breakthroughs in the future of drug discovery


  • PharmAbcine Inc. is a bio venture specialized in R&D of antibody treatment in the clinical stage and currently possesses core technologies such as potent antibody development technology using potent non-immune scFv phage display library, new-generation double target antibody production technology, and antibody production technology using cancer stem cell library. Since its establishment in 2008, the company is devoted to developing new cancer antibody drugs and laying a foundation for TTAC-0001 and PMC-001. PharmAbcine constantly develops pipelines for sustainable growth with a vision to release a new global blockbuster bio drug by 2020 and become a global bioengineering company


  • SEEDSUPPLY is a Japan-based drug research and development consultancy firm that promotes early drug discovery research of small molecule compounds and improve drug discovery research speed through its binder selection technology. SEEDSUPPLY's binder selection technology effectively explores compounds against drug targets with high sensitivity and convenience. The screening can be used for any type of target, as not only purified proteins, but also membrane fractions and microsomal fractions can be used


  • 3D BioOptima

    3D BioOptima

    3D BioOptima strives to best serve its clients with value-added solutions for their drug R&D programs of chemical and biological therapeutics by conducting specialized preclinical services, such as absorption, distribution, metabolism and excretion (ADME) characterization, pharmacokinetic and pharmacodynamic evaluation, bioanalysis, high-throughput ADME screening, ADME-assisted lead optimization, biological/pharmacological screening, large-molecule research, exploratory toxicity assessment, and regulatory consultation

  • Axcelead


    Axcelead Drug Discovery Partners, Inc. combines scientific excellence, world-class IP protection and state-of-the-art GLP accredited facilities and capabilities to deliver integrated end-to-end early discovery. Axcelead is the first comprehensive integrated drug discovery solutions provider in the pharmaceutical industry in Japan, having succeeded some portion of the drug discovery research department of Takeda Pharmaceutical Company Limited. and started its business on July 1, 2017

  • dMed


    dMed is a full-service Clinical Contract Research Organization (CRO), which provides industry solutions to pharmaceutical and medical device companies in China and across the globe. dMed is led by experts in China and the US who originated from leading multinational pharma companies and regulatory agencies. The company is uniquely positioned to leverage and integrate China’s new regulatory framework, offer innovative drug development strategies, and help clients expand globally by tapping into the world’s second-largest pharmaceutical market

  • Gemseki


    Gemseki is a global portal platform company that mediates drug and delivery technology candidates between in and out-licensors. The company's Drug Candidate Marketplace is a unique platform that connects those with drug and technology candidates with those who are looking for them

  • Genewiz


    GENEWIZ is a leading global genomics service company. A full-service provider, GENEWIZ provides DNA sequencing, gene synthesis, molecular biology, next-generation sequencing, bioinformatics, and GLP regulatory and clinical services. From the company’s founding, GENEWIZ has maintained its unwavering commitment to providing customers with the best value

  • Koru


    Koru can be best described as a pharmaceutical center of research in the age of agile, a fast-growing pharmaceutical research and development group, bringing together an expansive pool of high-value experts under one umbrella and offering complex, technologically advanced platforms targeting serious human disease Koru’s business model fundamentally depends on product innovation to create value by delivering greater customer benefits

  • Metabolon


    Metabolon provides actionable biological insights to answer the toughest questions in life sciences research and drug development. By producing the most accurate and comprehensive picture of the collection of metabolites, known as the metabolome, from a single biological sample, Metabolon can deliver an instantaneous snapshot of the entire physiology of a living being at a discreet point in time, as well as identify changes in that system brought about the impact of disease, medical intervention, diet or the environment